Abstract

Purpose: The IMPORT-LOW trial demonstrated non-inferiority of partial-breast radiotherapy (PBI) compared with standard whole breast radiotherapy (WBRT) with regards to local relapse in patients with early breast cancer with equivalent or fewer late normal tissue effects at 5 years [1]. This led to UK practice change, with selected low-risk patients offered PBI [2]. We aim to evaluate our single-centre experience by comparing volume of breast tissue treated, heart and lung dosimetry in patients treated with PBI compared to WBRT.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call